Alpha-1 adrenergic receptor and 5-alpha-reductase — Drug Target

All drugs that target Alpha-1 adrenergic receptor and 5-alpha-reductase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Alpha-1 adrenergic receptor antagonist and 5-alpha-reductase inhibitor

Phase 3 pipeline (1)

• tamsulosin and/or dutasteride · Case Comprehensive Cancer Center · Alpha-1 adrenergic receptor antagonist and 5-alpha-reductase inhibitor · Urology
  Tamsulosin and dutasteride are alpha-1 adrenergic receptor antagonists and 5-alpha-reductase inhibitors, respectively, used to treat benign prostatic hyperplasia (BPH) symptoms and reduce the risk of acute urinary retention and BPH-related surgery.